Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14216 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Catherine Aftandilian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Stanford Maternal and Child Health Research Institute.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T cell therapy is a promising treatment for pediatric patients with relapsed or refractory B cell acute lymphoblastic leukemia (R/R B ALL). Cytokine release syndrome (CRS) is a common toxicity after CAR T cell therapy and fever is often the first symptom. Differentiating CRS from infection after CAR T cell therapy can be challenging. Plasma microbial cell free DNA (mcfDNA) is a novel diagnostic tool which allows for qualitative and quantitative assessment of over 1000 organisms. This pilot study sought to characterize mcfDNA results in pediatric patients with R/R B ALL in the first 2 months after CAR T cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, California, USA.
- Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, California, USA.
- Karius Diagnostics, Redwood, California, USA.
- Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA.
- Nucleix Ltd., Rehovot, Israel.
ORCID-Profile: Catherine Aftandilian
Förderung
- Stanford Maternal and Child Health Research Institute
Zitieren
APA
Aftandilian, C., Bito, X. R., Berman, D., Zhang, A., Duttagupta, R., & Davis, K. L. (2024). Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia. European Journal of Haematology. https://doi.org/10.1111/ejh.14216
Vancouver
Aftandilian C, Bito XR, Berman D, Zhang A, Duttagupta R, Davis KL. Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia. European Journal of Haematology. 2024. doi:10.1111/ejh.14216
BibTeX
@article{Aftandilian2024,
author = {Aftandilian, Catherine and Bito, Xue Rachel and Berman, David and Zhang, Amy and Duttagupta, Radha and Davis, Kara L},
title = {Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14216}
}
EUVIMED